Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Oncology

• Publication date

  2013-09-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2013.49.5077PMID 24043739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modelling Survival Data in Medical Research

  2014cited by this paper
• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death

  2013cited by this paper
• Oncoplastic Breast Reduction: Maximizing Aesthetics and Surgical Margins

  2012cited by this paper
• Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

  2012cited by this paper
• Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

  2012cited by this paper
• Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes.

  2012cited by this paper
• Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

  2011cited by this paper
• Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

  2010cited by this paper
• Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

  2010cited by this paper
• Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

  2010cited by this paper
• Second solid cancers after radiotherapy for breast cancer in SEER cancer registries

  2009cited by this paper
• Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.

  2008cited by this paper
• Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.

  2008cited by this paper
• Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

  2007cited by this paper
• SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

  2006cited by this paper
• Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

  2006cited by this paper
• Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

  2006cited by this paper
• Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast

  2005cited by this paper
• Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.

  2005cited by this paper
• Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ.

  2005cited by this paper
• Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.

  2004cited by this paper
• Modelling Survival Data in Medical Research

  2004influential reference
• Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

  2002cited by this paper
• Significance and Assessment of Margin Status in Ductal Carcinoma In Situ of the Breast

  2001cited by this paper
• Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

  2001cited by this paper
• [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].

  1999cited by this paper
• Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

  1998cited by this paper
• Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.

  1998cited by this paper
• Modelling survival data

  1994cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper

• The impact of immune microenvironment on local control of ductal carcinoma in situ receiving breast conservative therapy

  2026cites this paper
• Quality of Life and Fear of Recurrence or Progression in Women With DCIS Who Did and Did Not Receive Radiotherapy.

  2025cites this paper
• Postoperative radiotherapy for ductal carcinoma in situ: survival prediction and clinical decision support using a nomogram-based approach

  2025cites this paper
• Trends and disparities in locoregional treatment of programme-detected ductal carcinoma in situ in New Zealand women, 1999-2022.

  2025cites this paper
• Safety Analysis of Omitting Radiotherapy After Breast‐Conserving Surgery in Patients With Early‐Stage Breast Cancer: A Meta‐Analysis Based on Randomized Controlled Trials

  2025cites this paper
• Managing ductal carcinoma in situ of the breast without surgery

  2025cites this paper
• Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ

  2025cites this paper
• American Radium Society Appropriate Use Criteria Report on Radiation in the Management of Ductal Carcinoma in Situ (DCIS) of the Breast.

  2025cites this paper
• Plasma Membrane TRPV4 Relocalization as a Mechanosensitive Prognostic Biomarker in Ductal Carcinoma In Situ

  2025cites this paper
• A systematic review on the management of ductal carcinoma in situ of the breast.

  2025cites this paper
• Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk

  2025cites this paper
• Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates.

  2025cites this paper
• Advancements in Detection and Management of Ductal Carcinoma in Situ.

  2025cites this paper
• Current pattern of care in radiation therapy for DCIS in Australia and New Zealand - where are we heading?

  2025influential citation
• One Week, One Boost, One Goal: Feasibility, Safety and Local Control in Breast Ductal Carcinoma In Situ With Ultra-hypofractionated Radiotherapy and Simultaneous Integrated Boost.

  2025cites this paper
• Impact of Postoperative Radiotherapy on the Risk of Ischemic Heart Disease and Survival in Patients with Ductal Carcinoma In Situ: A Nationwide Claims-Based Cohort Study

  2025influential citation
• Influence of Cancerization of Lobules in Ductal Carcinoma In Situ of the Breast on the Pathological Outcomes in Mastectomy Specimens

  2025cites this paper
• Relative Effects of Brachytherapy and Beam Radiation for DCIS on Subsequent Invasive Events

  2025cites this paper
• An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ

  2024cites this paper
• Consultant oncoplastic breasts surgeon

  2024cites this paper
• Advantages of single high-dose radiation therapy compared with conventional fractionated radiation therapy in overcoming radioresistance

  2024cites this paper
• Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.

  2024cites this paper
• Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study

  2024cites this paper
• Tools to Guide Radiation Oncologists in the Management of DCIS

  2024cites this paper
• Treatment and Outcome of Ductal Carcinoma in Situ for the German Federal States Berlin and Brandenburg in the Period 2007–2020

  2024cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

  2024cites this paper
• Impact of surgical types on overall survival in patients with ductal carcinoma in situ: an analysis based on the SEER database

  2024cites this paper
• Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade

  2024cites this paper
• Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives

  2024cites this paper
• Is It Time to Abandon Surgery for Low-Risk DCIS?

  2024cites this paper
• Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery

  2024cites this paper
• Re-Evaluating the Omission of Radiation Therapy in Low-Risk Patients With Early-Stage Breast Cancer.

  2024cites this paper
• Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor Zone

  2024cites this paper
• Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

  2024cites this paper
• Advancements in Managing Pure Ductal Carcinoma In Situ: An 18-Year Artificial Intelligence-Aided Analysis of 998 Patients

  2024cites this paper
• Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series

  2024cites this paper
• Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study

  2024cites this paper
• Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands-A Nationwide Overview From 2008 Until 2022.

  2024cites this paper
• De-Escalating Breast Cancer Therapy.

  2023cites this paper
• Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer

  2023cites this paper
• Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

  2023cites this paper
• Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ

  2023cites this paper
• Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency

  2023cites this paper
• Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ

  2023cites this paper
• Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?

  2023cites this paper
• DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation.

  2023cites this paper
• Changing trends in the management of ductal carcinoma in situ in Republic of Korea: a comprehensive analysis using Health Insurance Review and Assessment data [2009–2020]

  2023cites this paper
• HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!

  2023cites this paper
• Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial

  2023cites this paper
• Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.

  2023cites this paper
• Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.

  2023cites this paper
• Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ

  2023cites this paper
• Net survival of women diagnosed with breast tumours: a population-based study in Switzerland.

  2023cites this paper
• The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery

  2023cites this paper
• Radiation Management of DCIS and Elimination of RT in Low-risk Disease

  2023cites this paper
• Human Ductal Carcinoma In Situ: Advances and Future Perspectives.

  2023cites this paper
• Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.

  2023cites this paper
• Implicaciones de la pandemia en la radioterapia para el cáncer de mama. Omisión de la radioterapia

  2022cites this paper
• Indications for adjuvant radiotherapy in breast cancer Armenian consensus 2021-2022

  2022cites this paper
• Preoperative Magnetic Resonance Imaging Evaluation Improves Breast Conserving Surgery Rate but Not Local Disease Control in Breast Ductal Carcinoma in Situ Patients: A Propensity Score-matched Analysis with 742 Cases

  2022cites this paper
• Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer

  2022cites this paper
• Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS) of the breast

  2022cites this paper
• Correlation between Margin Width and Time to Local and Systemic Recurrence of Ductal Carcinoma in Situ

  2022cites this paper
• Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry

  2022cites this paper
• Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort

  2022cites this paper
• Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia

  2022cites this paper
• Long Term Clinical Outcome and Prognostic Factors after Treatment of Patients Diagnosed with Ductal Carcinoma in Situ of Breast

  2022influential citation
• A Novel Nomogram for Predicting Prognosis and Tailoring Local Therapy Decision for Ductal Carcinoma In Situ after Breast Conserving Surgery

  2022cites this paper
• Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

  2022cites this paper
• Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ

  2022cites this paper
• GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of Breast Cancer Cells

  2022cites this paper
• De-Escalating the Management of In Situ and Invasive Breast Cancer

  2022cites this paper
• Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression

  2022cites this paper
• Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery

  2022cites this paper
• Improving the well‐being of women with ductal carcinoma in situ: A worthy goal with an unclear route to success

  2022cites this paper
• Rural–urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis

  2022cites this paper
• Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma <i>In Situ</i>: Ki-67 Index as the Most Influential Prognostic Factor

  2022cites this paper
• Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI

  2022cites this paper
• Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast

  2022cites this paper
• Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS

  2022cites this paper
• Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions

  2022cites this paper
• Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy

  2022cites this paper
• Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast—15-Year Follow-Up

  2022influential citation
• Automated assessment of breast margins in deep ultraviolet fluorescence images using texture analysis.

  2022cites this paper
• Breast Irradiation in Ductal Carcinoma In Situ.

  2021cites this paper
• Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview.

  2021influential citation
• Management of breast cancer: basic principles

  2021cites this paper
• De-escalating Treatment for Ductal Carcinoma In Situ.

  2021cites this paper
• Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study

  2021cites this paper
• Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization

  2021cites this paper
• Intraoperative imaging in pathology-assisted surgery

  2021cites this paper
• Should Everyone With Ductal Carcinoma in Situ Receive Adjuvant Radiation?

  2021cites this paper
• A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices

  2021cites this paper
• Advances and controversies in management of breast ductal carcinoma in situ (DCIS).

  2021cites this paper
• Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of “preinvasive” disease

  2021cites this paper
• Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis

  2021cites this paper
• Assessment of the usefulness of prognostic Van Nuys Prognostic Index in the treatment in ductal carcinoma in situ in 15-year observation

  2021cites this paper
• Improving shared decision-making in breast cancer radiotherapy: development and implementation of a patient decision aid

  2021influential citation
• The 5-Year Paradigm in DCIS of the Breast: Unexpected Lessons From the NSABP B-43 Trial.

  2021cites this paper
• Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation

  2021cites this paper